Heavy Metals Guide · Brain

Heavy metals in the brain: brain fog and concentration

Nerve tissue uses a lot of oxygen, is packed with sensitive fatty acids and is especially dependent on working glutathione peroxidases. Metals can interfere exactly there. Whether they explain your brain fog is a different question, and studies answer it more cautiously than many websites do.

SJ
Shukri Jarmoukli · Physician, Integrative Medicine · ViveCura Berlin
Peroxidases, selenium, ferroptosis Occupational, population, animal data kept apart Provocation test, critically reviewed 66 verified sources, 64 of them with DOI
Why I'm writing this

When it comes to heavy metals in the brain, I keep running into two statements that both fall short. One says: your brain fog comes from metals, so get them out. The other says: that's nonsense, forget it. In between lies a question that can be checked, and it deserves a careful answer.

You read an email for the third time. The words are there, but they don't land. In the middle of a conversation, a word you have known for years just isn't there. And in the afternoon your head feels as if someone had stuffed it with cotton wool.

Many people know this pattern. At some point they come across the question of whether heavy metals in the brain could be behind it. Old dental fillings, water pipes in an old building, a job with dust and fumes.

Brain fog is not a diagnosis. It is an umbrella term for forgetfulness, trouble concentrating, slowed thinking and difficulty finding words. How the symptom picture shows up is described in the article Brain fog: recognizing the symptoms.

This article is about three other questions: Why is nerve tissue so sensitive? What do studies in humans show, separated into high and low exposure? And what can be checked without a questionable test or a risky detox doing harm?

Before you read on

When a foggy head is not something to wait out

Call 112 or go to the nearest emergency department right away if one of these signs appears for the first time:

  • acute confusion, marked drowsiness or impaired consciousness
  • new neurological deficits: weakness or numbness on one side of the body, speech problems, vision problems, a drooping corner of the mouth
  • a first seizure or a sudden, extremely severe headache
  • confusion together with fever and a stiff neck

Have it checked by a doctor promptly, within a few days: memory problems that progress quickly over weeks, personality changes that other people notice, or trouble finding your way in familiar surroundings.

If you have thoughts of suicide, get help right away. In Germany, you can reach the Telefonseelsorge crisis line at 0800 111 0 111 and 0800 111 0 222, around the clock and free of charge. In acute danger, call 112. These are German numbers; outside Germany, please contact your local emergency services or crisis line.

Suspected acute poisoning, for example after contact with larger amounts of mercury or after renovation work with lead dust, and now new symptoms: contact the poison control center (Giftnotruf) of your German federal state or call 112, and outside Germany your local poison control center or emergency number. This is not a case for a lab test in a few weeks.

And one sentence about medication that belongs here: Do not stop or reduce a prescribed medication on your own, even if you suspect it is clouding your mind. This applies to antidepressants, sleeping pills, painkillers, epilepsy medication, bladder medication and thyroid hormones. With sleeping pills and sedatives from the benzodiazepine and Z-drug groups, stopping abruptly after longer use can be dangerous, up to and including seizures. Any change belongs in the hands of the doctor who prescribed it.

First, a word on the evidence, so you can weigh things correctly:

Mechanism: well studiedCell and animal data show how metals can disrupt peroxidases and selenium in nerve tissue.
Humans: mixedSmall but consistent effects with high occupational exposure. Weak and partly contradictory associations at everyday levels.
Detox: no cognitive benefit shownA large randomized trial in lead-exposed young children lowered the blood level, but thinking did not improve. There is no controlled study on brain fog.

What to expect here

  • Why the brain has little reserve against oxidation
  • What glutathione peroxidases, GPX4 and ferroptosis have to do with it
  • Why the brain holds on to selenium so tightly
  • Mercury as a selenium and thiol binder
  • Lead, the NMDA receptor and cognition in adults
  • Cadmium, arsenic, manganese and a brief look at aluminum
  • The levels of evidence in one table
  • The more common causes of brain fog
  • Which measurement shows what, and why no provocation test
  • Detox and what you can do
Clinical Guideline, agency, randomized trial Human Observational study, meta-analysis Animal Study in mice or rats Cell Cell culture, mechanism review

Why the brain is so sensitive: oxygen, fats and peroxidases

Imagine a workshop where welding goes on around the clock. Sparks are flying everywhere. And the walls are made of dry wood. That, in simplified terms, is the situation of your nerve cells.

Thinking costs energy, and energy is produced in the mitochondria using oxygen. This creates reactive molecules, the sparks in this workshop.

Mechanism review Thirteen reasons for little reserve

A team led by Cobley compiled in a review why the brain in particular is so vulnerable to oxidative stress.

The human brain uses 20 percent of all the oxygen the body consumes at rest. On top of that come many unsaturated fatty acids, many mitochondria, calcium and glutamate signaling, redox-active metals and a rather modest antioxidant defense.

What this means for you: your brain works with a small safety margin. But reactive oxygen species also have signaling roles, so this is about balance, not about fighting every single radical.

Cobley JN, Fiorello ML, Bailey DM. Redox Biol. 2018;15:490-503. PMID: 29413961 · DOI: 10.1016/j.redox.2018.01.008 [Mechanism Review]

The dry wood: polyunsaturated fatty acids

The membranes of nerve cells contain many polyunsaturated fatty acids. They keep the membrane flexible, but they oxidize easily, a bit like butter turning rancid in the sun.

When such a fatty acid is oxidized, a lipid peroxide forms. The tricky part: a lipid peroxide can attack the next fatty acid. This can set off a chain reaction that eats its way through the membrane if nothing stops it.

The fire brigade: glutathione peroxidases

This is where the glutathione peroxidases come in. These enzymes defuse peroxides by using glutathione as an electron donor. GPx1 works mainly inside the cell on hydrogen peroxide. GPX4 specializes in rendering oxidized fats harmless directly in the membranes.

Both carry selenium in their active site, built in as the amino acid selenocysteine. And so that glutathione is available again and again, the cell needs glutathione reductase, which in turn depends on a vitamin B2 derivative. This is textbook biochemistry and explains why selenium and B2 keep being mentioned in this context. It does not follow that you should take them.

This is exactly what the sentence means with which the article Glutathione: the master antioxidant points to this page: nerve tissue is especially dependent on working peroxidases.

The protective chain in five steps

From oxygen to protection or to ferroptosis

  • Oxygen turnover: Mitochondria produce energy and, in the process, reactive molecules.
  • Lipid peroxide: Polyunsaturated fatty acids in the membrane oxidize, and a chain reaction can start.
  • GPX4 with selenium: The enzyme converts the lipid peroxide into a harmless alcohol, using up glutathione.
  • Resupply: Glutathione is regenerated, and vitamin E intercepts chain reactions in the membrane.
  • When protection fails: Iron can drive the chain reaction. The cell can then die in a distinct way, called ferroptosis.

This chain is well documented in cells and animal models. It has not been shown that brain fog in humans arises this way. It explains a vulnerability, not a diagnosis.

The last step of this chain was described in 2012 by a team led by Dixon in cancer cells and in rat brain slices: an iron-dependent cell death that the researchers named ferroptosis. An inhibitor blocked it, including the glutamate-induced cell death in the brain slices. This is laboratory knowledge, not a finding in humans.

What happens when GPX4 is missing in nerve cells

Is GPX4 merely useful for nerve cells, or indispensable? Two research groups switched off the enzyme selectively in mice.

A team led by Seiler showed in mice that the loss of GPX4 in nerve cells led to neurodegeneration. In cell culture, cell death could be completely prevented with vitamin E. That applied to the cell model and is not advice for humans.

Animal study, mouse Less peroxidase, poorer memory

A team led by Hambright selectively removed GPX4 in adult mice in nerve cells of the cerebral cortex and hippocampus, that is, in regions for thinking and memory.

From 12 weeks afterward, the animals showed clear deficits in spatial learning and memory in the water maze. In addition, there were more oxidized fats and signs of inflammation in the tissue. A diet low in vitamin E accelerated the decline, and an inhibitor of ferroptosis attenuated the neurodegeneration.

What this means for you: this is where the link text of the glutathione page becomes tangible. When the peroxidase is missing in the memory regions, the mouse learns less well. But a complete genetic knockout is not the same as slightly reduced activity in humans.

Hambright WS, Fonseca RS, Chen L, Na R, Ran Q. Redox Biol. 2017;12:8-17. PMID: 28212525 · DOI: 10.1016/j.redox.2017.01.021 [In vivo, mouse]

Why the brain holds on to selenium so tightly

For GPX4, selenium is not just any building block. A team led by Ingold swapped the selenocysteine in the enzyme for sulfur-containing cysteine in mice. That was enough for embryonic development. But a specific group of interneurons only survived with the selenium version; without it, fatal epileptic seizures occurred. In these cell and mouse data, selenium protected the enzyme from irreversible overoxidation.

Consistent with this, a research group led by Wirth found that without selenoproteins in nerve cells, developing interneurons in mice failed to express the marker parvalbumin, with epileptiform activity and progressive neurodegeneration. When only GPX4 was missing in nerve cells, fewer interneurons carried this marker.

Animal study, mouse A dedicated transport system for selenium

A team led by Burk studied mice lacking the transport protein selenoprotein P or its receptor ApoER2.

Without this system, the selenium content in the brain fell from about 120 to about 50 ng per gram of brain tissue, and even a mild selenium deficiency led to severe neurodegeneration. With the transport system intact, the animals even tolerated an extreme deficiency of about 12 ng per gram.

What this means for you: it is not only the amount that counts, but also whether selenium arrives where it is needed. Tissue levels in mice cannot be compared with human blood levels.

Burk RF, Hill KE, Motley AK et al. FASEB J. 2014;28(8):3579-3588. PMID: 24760755 · DOI: 10.1096/fj.14-252874 [In vivo, mouse]

In a review based mostly on animal data, Burk and Hill describe a hierarchy: when selenium becomes scarce, the liver releases selenoprotein P into the blood at the expense of its own selenoproteins, and distribution follows how well the organs are equipped with the receptor. The brain ranks high in this order. A serum level can therefore say only so much about the situation in nerve tissue.

Reframe

Sensitive does not mean fragile. The brain is a high-performance organ that affords itself its own protective architecture: peroxidases with selenium, a transport system for selenium and a hierarchy that favors nerve tissue when supplies are short.

So the useful question is not how to detox your brain, but what might be putting a strain on this protective architecture in your case.

And now you know why metals that attach to selenium and to sulfur groups could play a special role in nerve tissue in particular.

Mercury in the brain: the selenium and thiol thief

Maybe you have read that mercury is a selenium thief. It sounds like a headline. A surprising amount of it can be justified biochemically, and surprisingly little of it has been shown in humans in everyday life.

First, a distinction that is often missing. In their review, Clarkson and Magos name two important forms: mercury vapor from occupational exposure and from amalgam fillings, and methylmercury, which enters the diet mainly through fish. Form and source determine where it travels and how it is measured.

Cell study A look-alike gets past the barrier

A team led by Simmons-Willis used frog egg cells carrying human amino acid transporters to study how methylmercury gets into cells.

As a complex with the amino acid L-cysteine, methylmercury was taken up via the transporters LAT1 and LAT2, with Km values of 98 and 64 micromolar, compared with 99 and 161 micromolar for the amino acid methionine. As a complex with glutathione, it was not transported.

What this means for you: methylmercury can disguise itself as an amino acid and use transport routes that also exist at the blood-brain barrier. This is a laboratory finding; it explains a route, not an amount.

Simmons-Willis TA, Koh AS, Clarkson TW, Ballatori N. Biochem J. 2002;367(Pt 1):239-246. PMID: 12117417 · DOI: 10.1042/BJ20020841 [In vitro, oocyte expression system]

What mercury does to the peroxidases

Mercury preferentially attaches to sulfur groups, the thiols, and even more tightly to selenium groups, the selenols. In their review, based on cell and animal data, Farina and Aschner describe exactly these sites in the glutathione system as the most important molecular targets of methylmercury, with the nervous system as a preferred target.

Animal study, mouse Less peroxidase, more oxidized fats

A team led by Franco gave mice a high dose of methylmercury in their drinking water for 21 days and also studied human neuroblastoma cells.

In the brain, glutathione peroxidase activity fell and a marker of cell death rose. In mitochondria from the brain, reactive oxygen species and lipid peroxidation increased. An inhibitor of the peroxidase amplified the damage, while added peroxidase completely blocked lipid peroxidation.

What this means for you: the link between metal and peroxidase was measured directly here, but at a dose far above any everyday exposure.

Franco JL, Posser T, Dunkley PR et al. Free Radic Biol Med. 2009;47(4):449-457. PMID: 19450679 · DOI: 10.1016/j.freeradbiomed.2009.05.013 [In vivo, mouse, and In vitro]

In a follow-up study led by Zemolin using the same mouse model, GPx1, GPX4 and thioredoxin reductase fell in the cerebellum, while other protective enzymes tended to rise. So it was precisely the selenium-dependent enzymes that declined.

Ralston and Raymond go further: according to them, the affinity of mercury for selenium is about a million times greater than for sulfur. In their view, methylmercury irreversibly inhibits selenium-dependent enzymes, and when mercury and selenium are present in roughly equal amounts, a conditioned selenium deficiency develops in the tissue. According to their analysis, in animal experiments with low selenium intake, mercury doses were consistently neurotoxic and lethal, and markedly less so with normal selenium intake. This is a well-founded hypothesis based on mechanistic and animal data. In humans it has not been conclusively proven.

And in the human brain?

Autopsy study Two forms, two sources

A team led by Björkman measured the forms of mercury in blood and cerebral cortex in 30 deceased people aged between 47 and 91.

In blood, the median was 2.2 µg per liter of methylmercury and 1.0 µg per liter of inorganic mercury; in the cerebral cortex, 4 and 5 µg per kilogram. Methylmercury in blood and cerebral cortex was correlated. Inorganic mercury in blood and cerebral cortex was strongly associated with the number of amalgam surfaces.

What this means for you: diet and dental fillings leave different forms behind in the brain. Anyone who measures has to know what they are looking for.

Björkman L, Lundekvam BF, Laegreid T et al. Environ Health. 2007;6:30. PMID: 17931423 · DOI: 10.1186/1476-069X-6-30 [Autopsy study, n=30]

What matters to you, though, is whether mercury measurably changes thinking. Here the exposure levels have to be kept apart.

Meta-analysis Occupational exposure: small effect, barely visible in the individual

Rohling and Demakis pooled 36 studies with 2,512 people occupationally exposed to mercury and 1,846 controls.

The weighted mean effect size was -0.23, for psychomotor function -0.34 and for verbal comprehension -0.06. None of the exposure measures examined reached statistical significance. An effect of this size, they note, is typically not detectable in an individual person.

What this means for you: occupational exposure measurably shifts group averages. In a single person, this can hardly be read from one test.

Rohling ML, Demakis GJ. Clin Neuropsychol. 2006;20(1):108-132. PMID: 16393923 · DOI: 10.1080/13854040500203324 [Meta-analysis, k=36]

With dietary exposure, the picture is mixed. A team led by Yokoo studied 129 adults from fishing villages in Brazil where exposure was linked to fish consumption. Mercury levels in hair ranged from 0.56 to 13.6 µg per gram, and higher levels were associated, in a dose-dependent way, with weaker fine motor speed, weaker concentration and parts of verbal memory. This is a highly exposed special group and a cross-sectional study.

In the Baltimore Memory Study led by Weil, with 474 urban residents aged 50 to 70 and a median blood mercury of 2.1 µg per liter, higher levels were associated with poorer visual memory but better finger tapping. The authors saw no strong evidence of poorer performance.

Cross-sectional with MRI Weak but measurable, and not only in one direction

A team led by Takeuchi studied 920 healthy young adults in Japan with hair mercury, cognitive tests, a depression questionnaire and brain MRI.

Higher hair mercury was weakly but significantly associated with poorer performance, especially on speed tasks. At the same time, it was associated with a lower depressive tendency, with less gray matter in the thalamus and hippocampus and with less white matter in widespread areas. The authors speak of effects even at the levels common in Japan.

What this means for you: even at everyday levels, a weak link to thinking speed shows up at the group level. But a cross-sectional study does not prove cause.

Takeuchi H, Shiota Y, Yaoi K et al. Commun Biol. 2022;5(1):529. PMID: 35655003 · DOI: 10.1038/s42003-022-03464-z [Cross-sectional with MRI, n=920]
Reframe

A mechanism is a possibility, not a measurement in you. That mercury binds selenium and peroxidases in the mouse brain is well documented. That it causes the fog in your head does not follow from that.

Conversely, the question is not settled just because the effects are small. It belongs in a targeted medical history.

What mercury poisoning looks like and which sources come into question is covered in Mercury poisoning: recognizing the symptoms. You will find the debate about dental fillings in Amalgam and mercury. And now you know why the phrase about the selenium thief makes biochemical sense and still does not replace a diagnosis.

Lead, memory and concentration in adults

Lead sounds like yesterday's topic. And yet many adults wonder: can lead I was exposed to years ago still affect my memory today? The answer has two parts, the receptor and the storage.

The receptor for learning

Think of the NMDA receptor as a bouncer who decides whether a connection between two nerve cells gets strengthened. This very process is the basis of learning and memory. In their review, Neal and Guilarte describe that lead can selectively inhibit this receptor. Through a disrupted signaling chain involving the growth factor BDNF, presynaptic and postsynaptic effects can be connected. The data come mostly from animal models with exposure during development; for adults, this is a plausible mechanism.

What studies in workers show

Meta-analyses Subtle deficits with high occupational exposure

Meyer-Baron and Seeber pooled studies of workers with blood lead below 70 µg per 100 ml, and a later paper led by Seeber summarized two such meta-analyses with 24 publications.

They found deficits in tests of memory, attention and psychomotor function, including Block Design and Logical Memory. By convention, the effects were small. The first analysis compared their magnitude with performance changes due to up to 20 years of aging, and the summary spoke of subtle deficits at mean blood lead levels between 370 and 520 µg per liter.

What this means for you: with clearly elevated blood lead, subtle losses show up in areas that people describe as brain fog. Brain fog itself was not an endpoint, and the levels are far above everyday exposure.

Meyer-Baron M, Seeber A. Arch Toxicol. 2000;73(10-11):510-518. PMID: 10663381 · DOI: 10.1007/s002040050002 [Meta-analysis] · Seeber A, Meyer-Baron M, Schäper M. Arch Toxicol. 2002;76(3):137-145. PMID: 11967618 · DOI: 10.1007/s00204-001-0315-5 [Meta-analysis, summary]

With blood lead, pay attention to the unit. µg per deciliter and µg per liter differ by a factor of 10: 40 µg per deciliter is 400 µg per liter.

In 2007, a US expert panel led by Kosnett stated that the literature describes cognitive dysfunction in adults even below 40 µg per deciliter.

The storage in bone

Lead does not stay in the blood. Over the years it is deposited in bone, like sediment at the bottom of a lake. The blood level mainly shows what is currently circulating. Bone shows what has accumulated over a lifetime.

A systematic review led by Shih evaluated 21 studies that had measured both. With environmental exposure and in former workers, the associations with bone lead were stronger and more consistent than with blood lead; in currently exposed workers, it tended to be the other way round. Bone lead is measured with X-ray fluorescence, a pure research method.

Cohort, prospective Bone lead and faster decline

A team led by Weisskopf followed 466 older men from the Normative Aging Study who had no occupational exposure and took the Mini-Mental State Examination twice, on average 3.5 years apart.

An interquartile range of 20 µg lead per gram of kneecap bone was associated with a change in the Mini-Mental State Examination of -0.24 (95 percent confidence interval -0.44 to -0.05). This corresponded to about five years of aging. With tibia lead the association was weaker, and with blood lead it was absent.

What this means for you: the stored lead burden was associated with faster cognitive decline, the current blood level was not.

Weisskopf MG, Wright RO, Schwartz J et al. Am J Epidemiol. 2004;160(12):1184-1193. PMID: 15583371 · DOI: 10.1093/aje/kwh333 [Cohort, prospective, n=466]

Two further studies round out the picture. A team led by Stewart studied 532 former workers who, on average, had been exposed to organic lead 18 years earlier. In this cross-sectional study, higher tibia lead was associated with more frequent white matter lesions of grade 5 or higher on MRI, with an odds ratio of 1.042 per µg lead per gram of bone (95 percent confidence interval 1.021 to 1.063), and with smaller total brain volume. In 584 women from the Nurses' Health Study led by Power, by contrast, the association between tibia lead and cognitive decline was only suggested; the confidence interval included zero.

And at the lead levels that are common today?

This is probably the question that interests you most. And here the data contradict each other.

Cross-sectional, population-representative No measurable effect at common levels

A team led by Krieg analyzed adults aged 20 to 59 from the US survey NHANES III and set occupational studies using the same three neurobehavioral tests alongside them.

Blood lead ranged from 0.7 to 41.8 µg per deciliter, with a geometric mean of 2.51. After adjustment, there was no statistically significant association in the general population with reaction time, the symbol-digit test and serial digit learning. Occupationally exposed groups with a mean of 41.07 µg per deciliter, by contrast, consistently performed worse on reaction time and the symbol-digit test.

What this means for you: at everyday lead levels, this large study found no effect. The authors saw no indication of impairment below 25 µg per deciliter.

Krieg EF Jr, Chrislip DW, Crespo CJ et al. Public Health Rep. 2005;120(3):240-251. PMID: 16134563 · DOI: 10.1177/003335490512000305 [Cross-sectional, NHANES III, plus occupational studies]

The other side: Sasaki and Carpenter analyzed NHANES data from 2011 to 2014 covering 3,042 adults aged 60 and over. There, cadmium and lead in the blood were associated with poorer results on all three cognitive tests. Higher selenium, on the other hand, was strongly associated with better results. This too is a cross-sectional study, with older people and different tests. Both findings stand side by side.

A link to the first section: a team led by Pawlas divided 324 lead-exposed workers into two halves according to their serum selenium. With more selenium, glutathione peroxidase activity was 23 percent higher, and markers of oxidative damage were lower. The authors state explicitly that these data are not sufficient to recommend selenium beyond the normal diet, except in the case of deficiency. That is an argument for measuring, not for high dosing.

Reframe

A normal blood lead level today is good news about what is currently circulating. It is not an answer to the question of what has accumulated in bone over decades.

And an elevated level is a reason to look for the source, not yet proof of the cause of your fog.

Where lead can come from today and what lead poisoning looks like is described in Lead poisoning: sources and symptoms. And now you know why, with lead, your history sometimes tells more than the current lab value.

Cadmium, arsenic, manganese and a brief look at aluminum

Three other metals come up less often, even though they are well studied for the nervous system. Each has its own signature.

Cadmium: long retention, a leakier barrier

Cadmium is barely excreted and therefore remains in the body for a very long time. In their review, based mainly on cell and animal data, Wang and Du describe that cadmium can enter nerve cells via the olfactory pathway and make the blood-brain barrier more permeable.

In humans, there are indications from cross-sectional data. A team led by Li studied 2,068 US adults aged 60 and over. The median blood cadmium was 0.35 µg per liter. More cadmium in the blood was associated with slightly weaker cognitive scores: β = -0.11 (95 percent confidence interval -0.20 to -0.03), highest versus lowest quartile β = -0.14 (-0.25 to -0.03). A cross-sectional study does not clarify cause and effect.

Arsenic: drinking water and the hippocampus

Tyler and Allan summarize human and rodent data: even low arsenic concentrations could impair neurological function, especially in children. In animal models, arsenic can impair the hippocampus, the stress axis and the formation of new nerve cells. In Project FRONTIER led by O'Bryant, among 434 adults from rural regions, long-term low groundwater exposure, estimated from geographic data, was associated with weaker global cognition, slower processing and weaker immediate memory, again in a cross-sectional study.

Manganese: the speed metal

Manganese is an essential trace element. With overexposure, O'Neal and Zheng describe a picture that resembles Parkinson's disease without being identical to it, with disrupted dopamine signaling. In blood, manganese has a short half-life, in bone about eight to nine years, so a blood level can underestimate longer exposure.

Meta-analysis Slowing as the key finding

A team led by Meyer-Baron pooled 13 studies with 958 people occupationally exposed to manganese and 815 unexposed people.

Six test measures showed significant overall effects between d = -0.23 and -0.36. Four of them measured motor speed, two the speed of information processing. Larger effects were related more to inhalable manganese in the air than to manganese in the blood.

What this means for you: in these studies, manganese mainly affected speed, which is what many people describe as slowed thinking. This is about the air breathed at the workplace, not about manganese from food.

Meyer-Baron M, Knapp G, Schäper M, van Thriel C. Neurotoxicology. 2009;30(4):487-496. PMID: 19465050 · DOI: 10.1016/j.neuro.2009.05.001 [Meta-analysis, k=13]

Aluminum, just briefly

Aluminum is not a heavy metal in the strict sense, but it often comes up in this context. What is documented is a historical special situation, dialysis encephalopathy: in 1976, Alfrey and colleagues found 25 ppm aluminum in the gray matter of affected patients, 6.5 ppm in other deceased dialysis patients and 2.2 ppm in controls. The patients had received aluminum-containing phosphate binders. On the question of aluminum and Alzheimer's disease, the evidence is split: in a systematic review led by Soleimani, 26 of 54 studies found a positive association, and 24 found none or a negative one. A meta-analysis of four eligible studies found a strong association, though with high heterogeneity, and the authors see aluminum as likely one of several interacting risk factors. A separate article on aluminum is in preparation.

The overall view across many metals

Umbrella review 83 meta-analyses on ten metals

A team led by Song pooled 20 papers with 83 meta-analyses on ten metals and cognitive impairment and rated their quality.

17 meta-analyses reached moderate to high credibility according to GRADE. Positively associated with cognitive impairment were manganese in hair, drinking water and air, copper in blood, lead in blood and hair, and long-term low-dose mercury. Zinc in blood was inversely associated.

What this means for you: this comprehensive overview supports associations for lead, mercury and manganese. But cognitive impairment is not the same as brain fog, and an association is not a cause in your case.

Song Y, Chen Y, Fu Z et al. J Hazard Mater. 2025;498:139881. PMID: 40966995 · DOI: 10.1016/j.jhazmat.2025.139881 [Umbrella review, 83 meta-analyses]

The following overview is the heart of this article. It shows which statement holds at which level.

My own compilation from the cited studies, as of the research date, not a personal finding.
LevelWhat has been shown thereWhat this means for brain fog
Cell and animalIn cell and animal models, metals can lower peroxidase activity, bind selenium and thiols and disrupt NMDA signaling. Loss of GPX4 led to memory deficits in mice.Mechanistically plausible. Explains a vulnerability, not a diagnosis.
Occupational, high exposureMeta-analyses on lead, mercury and manganese find small, consistent deficits in memory, attention and speed.Documented at the group level. Often barely measurable in the individual.
Population, common levelsWeak associations for cadmium, lead, mercury and arsenic in some cross-sectional studies, none in others.Unclear and partly contradictory. No study with brain fog as an endpoint.
ReversibilityChelation therapy lowered blood lead in children, but cognition and behavior did not improve.A cognitive benefit of detox has not been shown in studies so far.
Practice hypothesisVoices from environmental medicine see a gap between blood and tissue levels and individual susceptibilities.A legitimate question, so far without controlled evidence for diagnostics or benefit.
Reframe

The question is not whether heavy metals can harm the brain. They can, with sufficient exposure. The question is whether that is a plausible lead in your case, with your history and your levels.

No symptom list answers that, but a careful exposure history does.

And now you know why the same body of studies can lead to two completely different headlines, depending on which row of the table gets quoted.

Brain fog causes: what is more common and should be checked first

Do you know the joke about the man who looks for his keys under the streetlight because that's where the light is? Something similar easily happens with brain fog. People search where an article or a test happens to shine its light. Heavy metals are a lead that can be checked, but rarely the first one.

Qualitative content analysis What people mean when they say brain fog

A team led by McWhirter analyzed posts on the platform Reddit in which people described their brain fog, and found 141 first-hand descriptions.

The most common themes were forgetfulness (51), difficulty concentrating (43), dissociative phenomena (34), cognitive slowing and effort (26), communication problems (22), a cotton-wool or pressure feeling in the head (10) and fatigue (9). As a cause, the writers most often named long COVID, in 60 of 570 attributions.

What this means for you: the more precisely you describe what is happening to you, the more targeted the search can be.

McWhirter L, Smyth H, Hoeritzauer I et al. J Neurol Neurosurg Psychiatry. 2023;94(4):321-325. PMID: 36600580 · DOI: 10.1136/jnnp-2022-329683 [Qualitative content analysis, 141 descriptions]
Guideline The German primary care guideline on fatigue

The DEGAM S3 guideline on fatigue (Müdigkeit) is aimed at the workup in general practice and explicitly names cognitive complaints such as brain fog as part of the symptom. It takes pollutants seriously and, when taking the history, asks among other things about lead, carbon monoxide and solvents.

Recommendation 5.3.1, grade of recommendation A: in primarily unexplained fatigue, blood glucose, a complete blood count, erythrocyte sedimentation rate or CRP, transaminases or γ-GT and TSH shall be determined. Recommendation 5.3.2, expert consensus: further laboratory or instrumental tests should only be carried out if there are abnormal previous findings or specific indications. In women of childbearing age, ferritin can also be measured. If indications of a toxic cause accumulate while the workup is otherwise unremarkable, referral to an occupational or environmental medicine facility should follow.

What this means for you: the guideline does not rule out pollutants. It puts a targeted history and a lean basic workup first and follows the metal lead when there are concrete indications.

Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM). Müdigkeit. S3-Leitlinie, AWMF-Register-Nr. 053-002, as of 11/2022. No DOI, no PMID. register.awmf.org [Guideline]

Which causes are more common? The overview is deliberately broad; much can be clarified with a history and a basic workup.

Sleep deprivation and sleep apnea

A meta-review led by Olaithe analyzed 18 reviews, seven of them on sleep apnea, and found deficits in attention, memory, executive function, psychomotor function and language in untreated sleep apnea. More in Recognizing sleep apnea.

Depression and anxiety

Concentration problems are part of depression itself. It is a serious illness and deserves treatment, see Burnout or depression.

Post-COVID

Persistent cognitive complaints after an infection are measurable; figures below this overview.

Thyroid

Overt hypothyroidism is associated with cognitive losses that can largely reverse with treatment (Samuels). More in Thyroid: normal values, symptoms anyway.

Iron deficiency, even without anemia

A randomized trial led by Murray-Kolb found weaker cognitive performance in young women with iron deficiency. Details in Iron deficiency and brain fog.

Vitamin B12 deficiency

A deficiency can affect nerves and thinking. How it is measured is covered in Measuring vitamin B12 deficiency.

Blood sugar

According to DEGAM, blood glucose is part of the basic workup. Strong fluctuations can show up as dips in concentration, see Blood sugar and cortisol.

Menopause

Cognitive changes during menopause are common, as described by the International Menopause Society. See Perimenopause: symptoms.

Medications

Anticholinergic and sedating drugs can dampen thinking. They belong on the list, but are never stopped on your own.

Alcohol and other substances

They belong honestly in the history, because they can affect sleep and how you function during the day.

Mold and mycotoxins

Damp damage at home or at work is a separate lead, described in Brain fog and mycotoxins.

ME/CFS

Cognitive complaints that worsen after exertion deserve their own workup, see Chronic fatigue.

Functional cognitive disorder

Real, distressing thinking problems without brain damage. Functional means altered function, not imagined.

Migraine, head injury, chronic stress

These too can impair concentration and speed and belong in the history.

Some of these points deserve more numbers, because they often get lost in conversations about heavy metals.

Meta-analysis Depression affects thinking, even in remission

A team led by Rock pooled standardized test data from people with acute and with remitted depression.

In the acute phase, there were moderate deficits in executive function, memory and attention, with effect sizes between -0.34 and -0.65. In remission, executive and attention deficits persisted (-0.52 to -0.61), while the memory deficits were no longer significant (-0.22 to -0.54).

What this means for you: concentration problems are part of depression and can remain even after mood improves. That is a reason for treatment and patience, not for self-blame. Depression cannot be reduced to metals, nutrients or the gut, and no search for metals should interrupt or postpone ongoing psychotherapy or psychiatric treatment.

Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Psychol Med. 2014;44(10):2029-2040. PMID: 24168753 · DOI: 10.1017/S0033291713002535 [Meta-analysis]

Post-COVID is the second major lead. In an English population study led by Hampshire with 112,964 adults, people after Covid-19 whose symptoms had subsided in less than four weeks or after at least twelve weeks scored -0.23 and -0.24 standard deviations compared with the group without Covid-19. With persistent symptoms, it was -0.42 (95 percent confidence interval -0.53 to -0.31). Test performance was only weakly related to the reported brain fog. A meta-analysis led by Ceban found, twelve weeks or more after diagnosis, a proportion of 0.22 with cognitive impairment (95 percent confidence interval 0.17 to 0.28; n = 13,232), with very high heterogeneity between studies (I² 98.0 percent).

The third lead often lies in the medicine cabinet. In a nested case-control study led by Coupland with 58,769 dementia cases and 225,574 controls, the adjusted odds ratio for dementia rose from 1.06 (95 percent confidence interval 1.03 to 1.09) in the lowest to 1.49 (1.44 to 1.54) in the highest exposure category of anticholinergic medications. This is an observational study on dementia, not on brain fog. It does not follow that you should stop any medication. Bring your complete medication list to your appointment; any change belongs in the hands of the doctor who prescribed it.

This is also easily overlooked: according to a systematic review led by McWhirter, about a quarter of people in memory clinics received diagnoses that could point to a functional cognitive disorder, typically with a non-progressive course and a very critical self-assessment. The authors warn of harm from wrong labels, and that also applies to a hasty diagnosis of poisoning.

If what you are missing is energy rather than clarity, Heavy metals and fatigue is a better fit.

Reframe

Finding a common cause is not a consolation prize. Sleep apnea, iron deficiency or unrecognized hypothyroidism are often readily treatable.

Starting with them does not rule out the metal lead. It only prevents that lead from having to explain something that has a different cause.

And now you know why a good workup for brain fog starts broad and only then becomes more specific.

Which measurement shows what, and why no provocation test

Maybe there is a lab report in front of you with red markings and a recommendation to detox. Before you get alarmed, ask: what was measured, in which sample and after what preparation?

The principle: form and question determine the sample

  • Whole blood tends to reflect current exposure. For methylmercury it is more informative, because this form sits mainly in the red blood cells and, in Björkman's study, correlated with the level in the cerebral cortex.
  • Urine is better suited for inorganic mercury from vapor or amalgam. For the amalgam question, the RKI commission prefers measurement in urine. For cadmium in urine, the Human Biomonitoring Commission of the German Federal Environment Agency has updated its assessment values.
  • Blood lead shows the current lead exposure. The cumulative store in bone can only be determined with a research method.
  • Manganese in blood can underestimate longer exposure.
  • Hair analyses raise their own questions, discussed in Hair mineral analysis for heavy metals.

Reference values describe the usual background exposure of the population. They are not health limits and differ by laboratory and method, which is why there is deliberately no table of numbers here. The Human Biomonitoring Commission even withdrew its health-based assessment values for lead in blood. Interpreting a single value yourself and deriving a treatment from it therefore makes no sense. The details on measurement methods are in Measuring heavy metals: blood, urine or hair.

The provocation test: why it does not work as proof

In a provocation test, a chelating agent such as DMPS or DMSA is given and urine is then collected. The idea: what the chelating agent pulls out shows the burden in the tissue. The problem: chelating agents increase metal excretion in almost everyone.

Position statement The professional society for medical toxicology

In 2017, the American College of Medical Toxicology reaffirmed its position on urine testing after chelator administration and published the full text with its rationale.

These tests, it states, are scientifically not validated, have no proven benefit and are potentially harmful. Chelating agents increase excretion in healthy and exposed people alike, there are no accepted reference values for post-provocation samples, and in several human studies the tests could not distinguish exposed from unexposed people. DMSA and DMPS could also wash out essential elements and redistribute metals such as mercury within the body.

What this means for you: an elevated value after provocation mainly shows that a chelating agent was given. It is not suitable as evidence that metals are the cause of your brain fog.

American College of Medical Toxicology. J Med Toxicol. 2017;13(4):352-354. PMID: 28726084 · DOI: 10.1007/s13181-017-0624-6 [Position statement, professional society]
Cross-sectional with control group Documented exposure, still no signal

A team led by Frumkin gave DMSA to 119 former workers of a chloralkali plant with documented mercury exposure and to 101 controls, and collected 24-hour urine before and after.

Mean mercury excretion rose from 4.3 to 7.8 µg in 24 hours. However, past occupational exposure was not related to excretion either before or after DMSA, nor to the number of amalgam surfaces.

What this means for you: the provocation test did not even detect a documented past exposure. The authors considered the years that had passed since exposure ended the most likely reason.

Frumkin H, Manning CC, Williams PL et al. Environ Health Perspect. 2001;109(2):167-171. PMID: 11266328 · DOI: 10.1289/ehp.01109167 [Cross-sectional with control group, n=220]

Two further voices come to the same conclusion. In a review, Ruha states that there is no standardized, validated provocation test and advises against using these tests. And in 2007, on the amalgam question, the Commission on Methods and Quality Assurance in Environmental Medicine at the Robert Koch Institute wrote that mobilizing mercury with chelating agents before a urine measurement is not suitable for patient-related diagnostics.

Opposing view

What the other side asks us to consider

Within the same RKI commission, two members, Daschner and Mutter, did not support the recommendations and issued a dissenting opinion. Their argument: mercury accumulates in tissues, and the levels in blood and urine do not closely reflect this tissue burden. Individual susceptibilities, some of them genetic, were not sufficiently taken into account.

From naturopathic and functional practice, Crinnion argues that a sample taken after a mobilizing agent reflects the total body burden, and recommends measurements before and after provocation.

My assessment: the concern that blood and urine do not show everything is legitimate. But it does not make the provocation test valid, because the claim that it reflects the total body burden has not been confirmed in controlled investigations such as Frumkin's.

Reframe

A test that produces an elevated value in almost everyone does not answer a question. It creates one, and that question often leads to a treatment whose benefit for thinking has not been shown.

A good measurement therefore does not start in the lab, but with the question of which source is plausible in your case.

More on the provocation test and its history is in The DMPS provocation test. And now you know why a red arrow on a lab report only means something once it is clear how it came about.

Detoxing heavy metals from the brain? What studies on chelation therapy show

The idea is understandable. What doesn't belong in the body should come out. Chelating agents can bind metals and flush them out via the kidneys. What could be more obvious?

But lowering a blood level is one thing, improving thinking is another. And on exactly that, there is one large randomized trial.

RCT, n=780 Blood level lowered, thinking not improved

In the TLC trial led by Rogan, 780 young children aged 12 to 33 months with blood lead levels between 20 and 44 µg per deciliter received, double-blind, up to three 26-day courses of the chelating agent succimer, that is DMSA, or placebo. All families first received measures against lead sources in their homes.

During the first six months, blood lead under succimer was on average 4.5 µg per deciliter lower (95 percent confidence interval 3.7 to 5.3). After 36 months, IQ under succimer was 1 point lower than under placebo, behavior as rated by parents was slightly worse, and the neuropsychological test battery was slightly better. All differences were small and not significant. The follow-up led by Dietrich in 647 children at age seven also found no benefit for cognition, behavior and motor skills.

What this means for you: lowering the blood level did not improve thinking here. It was about children and lead, not about adults with brain fog, but it is considered the key randomized trial on reversibility. The authors emphasize how important it is to reduce lead sources in the environment.

Rogan WJ, Dietrich KN, Ware JH et al. N Engl J Med. 2001;344(19):1421-1426. PMID: 11346806 · DOI: 10.1056/NEJM200105103441902 [RCT, n=780] · Dietrich KN, Ware JH, Salganik M et al. Pediatrics. 2004;114(1):19-26. PMID: 15231903 · DOI: 10.1542/peds.114.1.19 [RCT, follow-up, n=647]

When chelation may be medically indicated

This does not mean that chelation therapy never makes sense. The expert panel led by Kosnett describes a role as an adjunctive measure in heavily exposed adults with symptomatic lead poisoning. For people without symptoms and with low blood lead levels, it is explicitly not recommended there. First place in these recommendations goes to ending the exposure.

In 2007, the RKI commission stated for nonspecific complaints that the effectiveness of mercury detox with chelating agents or of removing amalgam fillings is, as a rule, not established in such cases. The German primary care guideline on fatigue likewise does not derive a recommendation for amalgam removal.

Case series Not a harmless wellness procedure

A team led by Brown reported on deaths that were reported to the US public health agency CDC between 2003 and 2005.

Three people died of cardiac arrest due to a calcium level that was too low during chelation therapy, including two children. Both children had received edetate disodium.

What this means for you: chelation therapy can intervene deeply in the mineral balance and belongs in experienced medical hands. According to the ACMT, DMSA and DMPS can also wash out essential elements and redistribute mercury.

Brown MJ, Willis T, Omalu B, Leiker R. Pediatrics. 2006;118(2):e534-e536. PMID: 16882789 · DOI: 10.1542/peds.2006-0858 [Case Reports, case series]

The functional perspective deserves a fair hearing too: Sears describes the body's own chelators such as glutathione and metallothionein, sees successes of chelation in kidney, cardiovascular and neurological diseases and calls for renewed attention to it. The review does not include a controlled study on brain fog.

Clinical tradition without a strong study base: cilantro, chlorella and similar agents are used for detox in naturopathic practice; controlled studies with a cognitive endpoint are lacking. What is known about them is described in Detoxing heavy metals naturally. How glutathione is assessed in this context is covered in Glutathione and heavy metals. Medical chelation therapy with DMSA is explained in DMSA chelation therapy, its risks in Chelation therapy: side effects and risks.

The sentence to remember

No detox on your own. Chelating agents from the internet, protocols from forums or combinations put together by gut feeling can shift minerals and redistribute metals. Chelation therapy requires a measured, relevant exposure and a medical indication.

Reframe

Detoxing feels active, searching for sources feels passive. The evidence suggests the reverse order: ending the source comes first in the expert recommendations and is likely to have the best balance of benefit and risk.

If detox is medically indicated, then for a measurable reason.

And now you know why the question is not how to get heavy metals out of the brain, but whether, and why, they are a problem there at all.

What you can do: sources, basic workup, sleep, iron and selenium in moderation

So what do you do now with your fog? Clarity in your head is not a minor matter. It decides whether you steer your everyday life or it steers you. That is why it is worth putting the search in order.

First: check sources honestly

In the expert recommendations led by Kosnett, identifying and ending a source of exposure comes first. With these questions, you can sort your history for the conversation with your doctor:

Questions for your exposure history

  • Do you work, or did you work in the past, with metal dust, metal fumes, batteries, ammunition, glazes, measuring instruments or solvents?
  • Do you have hobbies such as soldering, shooting or sanding old paint?
  • Do you live in an old building that might still have old water pipes? Pointers on this are in the article on lead sources.
  • Do you smoke, or are you regularly exposed to tobacco smoke? Tobacco smoke is considered a known source of cadmium.
  • Do you take supplements or powders of unclear origin?
  • Was there a specific incident, such as a broken mercury thermometer or a renovation with a lot of dust?

If there is a well-founded suspicion of relevant occupational exposure, the DEGAM guideline states that a notification of suspected occupational disease is required. That is a route through occupational medicine, not through a specialty lab from the internet.

Second: basic workup before specialty tests

The basic workup in the DEGAM guideline, with blood sugar, complete blood count, an inflammation marker, liver values and TSH, is lean. Ferritin can be a useful addition, according to the guideline for example in women of childbearing age, and vitamin B12 when there are matching indications. A targeted metal measurement makes sense when your history provides a concrete indication, and then in the appropriate sample.

Third: take sleep and iron seriously

Sleep is the time when the brain recovers. If you snore, wake up with headaches in the morning or nod off during the day, you should have sleep apnea checked. Iron is needed, among other things, for energy production in the cells. Iron deficiency can exist even without anemia, as Functional iron deficiency explains.

Fourth: measure selenium instead of guessing

After everything you have read about GPX4 and selenium, one thought is tempting: then I'll just take selenium. This is exactly where caution pays off. With selenium, what you need and too much are close together.

Agency position The upper limit of the European Food Safety Authority

In 2023, the EFSA expert panel re-evaluated the tolerable upper intake level for selenium and chose hair loss as an early, well-documented sign of selenium excess.

From the large randomized SELECT trial, it derived a lowest dose with observed adverse effects of 330 µg per day and, after applying an uncertainty factor, set a tolerable upper intake level of 255 µg per day for adults, including pregnant and breastfeeding women. According to the panel, it is likely to be exceeded only with regular intake of high-dose supplements or regular consumption of Brazil nuts.

What this means for you: this number is an upper limit for total intake, not a recommendation. Brazil nuts are very rich in selenium and count toward it.

EFSA NDA Panel, Turck D, Bohn T, Castenmiller J et al. EFSA J. 2023;21(1):e07704. PMID: 36698500 · DOI: 10.2903/j.efsa.2023.7704 [Agency document, scientific opinion]

Three studies show why more is not automatically better. In an outbreak in the US led by MacFarquhar, a liquid supplement contained 200 times the stated amount of selenium due to a manufacturing error. Among 201 affected people with a median estimated intake of 41,749 µg per day, diarrhea occurred in 78 percent, fatigue in 75 percent and hair loss in 72 percent. After 90 days or longer, 35 percent still reported fatigue. So too much selenium can itself make you tired.

In a randomized trial led by Stranges, 1,202 people received 200 µg selenium per day or placebo, for an average of 7.7 years. This is a study figure, not a recommendation. Type 2 diabetes occurred at 12.6 cases per 1,000 person-years under selenium and 8.4 cases per 1,000 person-years under placebo, hazard ratio 1.55 (95 percent confidence interval 1.03 to 2.33). Diabetes was a secondary endpoint there.

And in PREADViSE led by Kryscio, an extension of SELECT, 7,540 men aged 60 and over received vitamin E, selenium, both or placebo. Dementia occurred in 325 of 7,338 men. The hazard ratios compared with placebo were 0.88 (0.64 to 1.20) for vitamin E, 0.83 (0.60 to 1.13) for selenium and 1.00 (0.75 to 1.35) for the combination. None of the supplements prevented dementia. This stands alongside Sasaki's cross-sectional finding of better test results with higher selenium: an association in observational data is not yet a benefit from taking it.

The sensible path is therefore to have your selenium status determined by a doctor when there is a reason for it, and to see your diet as the foundation. How selenium interacts with zinc and copper and why single supplements can tip the balance is covered in Minerals in balance. Its role for the thyroid is described in Selenium, zinc, iron and vitamin D for the thyroid.

Separate considerations apply to pregnant and breastfeeding women and to children. They are summarized in Heavy metals in pregnancy and in children.

My view from the consulting room

Clinically, I observe that people with brain fog have often already been searching for a long time, with many individual findings and no overall picture. Simple explanations in one direction or the other rarely do justice to this set of complaints. This is an experience from practice, not a study result.

I take brain fog seriously as a signal and prefer a thorough workup to a one-sided one: the symptom picture, sleep, mood, medications, hormones, iron, thyroid and an exposure history covering work, home and past history. Heavy metals are one lead among several in this.

If a measurement makes sense, then in the appropriate sample and without provocation. I prefer to support the selenium and glutathione system through a measured status and diet, not through megadoses. And for me, chelation therapy only comes into question with a clear medical indication.

Reframe

To think more clearly, you don't necessarily have to detox your brain. You are allowed to find out what is currently weighing on it. Sometimes that is a metal. More often it is something that is easier to find and address.

And now you know why the order of source, basic workup, sleep, iron and measured selenium makes more sense than any detox on suspicion.

Frequently asked questions about heavy metals, brain fog and concentration

Can heavy metals cause brain fog?

With high, mostly occupational exposure, meta-analyses show small but consistent deficits in memory, attention and speed, for example for lead, mercury and manganese. At everyday levels, the picture is unclear: some cross-sectional studies find weak associations, others no clear one. There is no study with brain fog as an endpoint. Heavy metals are therefore a lead that can be checked, but rarely the first one.

What symptoms can heavy metals cause in the brain?

In studies of occupationally exposed people, the main findings were subtle losses in memory, attention, psychomotor function and processing speed. With mercury, psychomotor function was most affected; with manganese, speed. These complaints are nonspecific. Exposure cannot be inferred from symptoms alone, because poor concentration can have many different causes.

Why is the brain particularly sensitive to oxidative stress?

The human brain uses 20 percent of the oxygen the body consumes at rest. Its membranes contain many unsaturated fatty acids that oxidize easily, and its antioxidant defense is rather modest. But reactive oxygen species also have important signaling roles; it is about balance.

What is glutathione peroxidase, and why does nerve tissue need it?

Glutathione peroxidases are selenium-containing enzymes that defuse peroxides with the help of glutathione. GPX4 renders oxidized fats harmless directly in the membranes. In mouse studies, the targeted loss of GPX4 in nerve cells led to neurodegeneration and, in memory regions, to learning and memory deficits from 12 weeks onward. This does not establish a link to brain fog in humans.

What is ferroptosis?

Ferroptosis is a form of cell death described in 2012 that depends on iron and oxidized membrane fats and does not follow classic apoptosis. It was described in cancer cells and rat brain slices, and GPX4 with selenium is considered a central protection against it. Ferroptosis is a cellular mechanism, not a diagnosis that can be measured in a lab in humans.

How can mercury harm the brain?

In laboratory experiments, methylmercury entered cells as a complex with the amino acid cysteine via amino acid transporters. It binds to sulfur and selenium groups and, in the mouse brain, lowered the activity and amount of selenium-dependent peroxidases. According to a hypothesis by Ralston and Raymond, this can create a local selenium deficiency. These are cell and animal data with high doses; in humans, the hypothesis has not been conclusively proven.

Does lead impair memory and concentration in adults?

With high occupational exposure, meta-analyses show subtle deficits. In older men, the lead stored in bone was associated with faster cognitive decline, roughly equivalent to five years of aging, while the current blood level was not. At common blood lead levels, NHANES III found no significant association with simple neurobehavioral tests, whereas a later analysis in older adults did.

What are the most common causes of brain fog?

Usually more likely than heavy metals are lack of sleep and sleep apnea, depression and anxiety, post-COVID, an underactive thyroid, iron deficiency even without anemia, vitamin B12 deficiency, blood sugar problems, menopause, sedating medications, alcohol, mold in the home, ME/CFS and functional cognitive disorders. The DEGAM guideline on fatigue puts the medical history and a basic workup first; further tests should only follow if there are specific indications.

Which test reliably shows heavy metal exposure?

There is no single test for everything. Which sample makes sense depends on the metal and its form: whole blood rather for methylmercury and current lead exposure, urine rather for inorganic mercury from vapor or amalgam. Reference values describe background exposure, depend on the laboratory and should be interpreted by a doctor.

Does a DMPS or DMSA provocation test make sense?

The American College of Medical Toxicology advises against it: these tests are not validated, have no proven benefit and are potentially harmful. Chelating agents increase metal excretion in almost everyone. In former mercury workers, excretion after DMSA rose from 4.3 to 7.8 µg in 24 hours, but was not related to their past exposure. The RKI commission also considered the DMPS test unsuitable.

Can heavy metals be detoxed from the brain?

Chelating agents can bind metals and flush them out; whether that improves thinking is a different question. In the randomized TLC trial, the chelating agent succimer lowered blood lead in 780 lead-exposed young children, but cognition and behavior did not improve, not even up to the age of seven. There is no controlled study for adults with brain fog, and detoxing on your own can cause harm.

Is chelation therapy dangerous?

It can be. In the US, three deaths from calcium levels that were too low during chelation therapy were reported between 2003 and 2005, two of them in children after edetate disodium. DMSA and DMPS can wash out essential elements and redistribute mercury. According to US expert recommendations, chelation can be considered as an adjunct in heavily exposed adults with symptomatic lead poisoning, not in people without symptoms and with low levels.

Should I take selenium for brain fog?

Not on suspicion. EFSA has set 255 µg per day as the tolerable upper intake level for total intake in adults; that is not a recommendation. In a poisoning outbreak caused by a faulty supplement, 75 percent suffered from fatigue; with 200 µg per day, type 2 diabetes occurred more often in a randomized trial; and in PREADViSE, selenium did not prevent dementia. It makes more sense to have your selenium status determined by a doctor when there is a good reason.

When should I seek medical help right away for brain fog?

Immediately via 112 or the emergency department in case of acute confusion, new paralysis, speech or vision problems, a first seizure, a sudden extremely severe headache or confusion with fever and a stiff neck. You should have memory problems that progress quickly over weeks checked by a doctor promptly. If you have thoughts of suicide, you can reach the Telefonseelsorge crisis line around the clock at 0800 111 0 111 or 0800 111 0 222, and in acute danger call 112. These are German numbers; outside Germany, please contact your local emergency services or crisis line.

Where this article connects to the rest of the blog

SJ

Shukri Jarmoukli

Physician, Integrative Medicine · ViveCura Berlin

In my private practice, I work at the intersection of conventional medicine, functional medicine, environmental medicine and Clinical Psychoneuroimmunology. With brain fog, I am interested in which of the possible causes has never been looked at carefully in a particular person.

With heavy metals, I am deliberately cautious: the mechanism is well studied in cell and animal models, but a benefit of detox for thinking has not been shown. This article does not replace medical advice and is not a guide to changing a treatment or starting a detox.

ViveCura, Privatpraxis Shukri Jarmoukli, Skalitzer Straße 137, 10999 Berlin

Scientific sources

Guidelines, agencies and professional societies

  1. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM). Müdigkeit (Fatigue). S3-Leitlinie, AWMF-Register-Nr. 053-002, DEGAM-Leitlinie Nr. 2. As of 11/2022. No DOI, no PMID. register.awmf.org [Guideline]
  2. American College of Medical Toxicology. ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing. J Med Toxicol. 2017;13(4):352-354. PMID: 28726084 · DOI: 10.1007/s13181-017-0624-6 [Position statement, professional society]
  3. Commission "Methods and Quality Assurance in Environmental Medicine" at the Robert Koch Institute. [Amalgam: orientation from the environmental medicine viewpoint. Report of the "Methods and Quality Assurance in Environmental Medicine" Committee]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(10):1304-1307. PMID: 17924071 · DOI: 10.1007/s00103-007-0338-z [Agency document, commission statement]
  4. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA); Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Peláez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Aggett P, Crous Bou M, Cubadda F, Ciccolallo L, de Sesmaisons Lecarré A, Fabiani L, Titz A, Naska A. Scientific opinion on the tolerable upper intake level for selenium. EFSA J. 2023;21(1):e07704. PMID: 36698500 · DOI: 10.2903/j.efsa.2023.7704 [Agency document, scientific opinion]
  5. Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, Hu H, Woolf A. Recommendations for medical management of adult lead exposure. Environ Health Perspect. 2007;115(3):463-471. PMID: 17431500 · DOI: 10.1289/ehp.9784 [Review, expert recommendation]
  6. Schulz C, Wilhelm M, Heudorf U, Kolossa-Gehring M; Human Biomonitoring Commission of the German Federal Environment Agency. Update of the reference and HBM values derived by the German Human Biomonitoring Commission. Int J Hyg Environ Health. 2011;215(1):26-35. PMID: 21820957 · DOI: 10.1016/j.ijheh.2011.06.007 [Agency document, Human Biomonitoring Commission]

Opposing views

  1. Daschner F, Mutter J. [Special vote on "Amalgam: statement on its environmental medical impact", report of the commission "Methods and Quality Assurance in Environmental Medicine" of the Robert Koch Institute, Berlin]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(11):1432-1433. PMID: 17999137 · DOI: 10.1007/s00103-007-0399-z [Dissenting opinion, expert opinion]
  2. Crinnion WJ. The benefits of pre- and post-challenge urine heavy metal testing: Part 1. Altern Med Rev. 2009;14(1):3-8. PMID: 19364190 · no DOI [Case Reports, position paper]
  3. Sears ME. Chelation: harnessing and enhancing heavy metal detoxification: a review. ScientificWorldJournal. 2013;2013:219840. PMID: 23690738 · DOI: 10.1155/2013/219840 [Review, narrative]

Mechanism: oxygen, peroxidases, selenium

  1. Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018;15:490-503. PMID: 29413961 · DOI: 10.1016/j.redox.2018.01.008 [Mechanism Review]
  2. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060-1072. PMID: 22632970 · DOI: 10.1016/j.cell.2012.03.042 [In vitro, cell study and rat brain slices]
  3. Seiler A, Schneider M, Förster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8(3):237-248. PMID: 18762024 · DOI: 10.1016/j.cmet.2008.07.005 [In vivo, mouse, and In vitro]
  4. Hambright WS, Fonseca RS, Chen L, Na R, Ran Q. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol. 2017;12:8-17. PMID: 28212525 · DOI: 10.1016/j.redox.2017.01.021 [In vivo, mouse]
  5. Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T, Mehr L, Aichler M, Walch A, Lamp D, Jastroch M, Miyamoto S, Wurst W, Ursini F, Arnér ESJ, Fradejas-Villar N, Schweizer U, Zischka H, Friedmann Angeli JP, Conrad M. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell. 2018;172(3):409-422.e21. PMID: 29290465 · DOI: 10.1016/j.cell.2017.11.048 [In vivo, mouse, and In vitro]
  6. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, Schmitz D, Bornkamm GW, Coppola V, Tessarollo L, Schomburg L, Köhrle J, Hatfield DL, Schweizer U. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J. 2010;24(3):844-852. PMID: 19890015 · DOI: 10.1096/fj.09-143974 [In vivo, mouse]
  7. Burk RF, Hill KE, Motley AK, Winfrey VP, Kurokawa S, Mitchell SL, Zhang W. Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. FASEB J. 2014;28(8):3579-3588. PMID: 24760755 · DOI: 10.1096/fj.14-252874 [In vivo, mouse]
  8. Burk RF, Hill KE. Regulation of Selenium Metabolism and Transport. Annu Rev Nutr. 2015;35:109-134. PMID: 25974694 · DOI: 10.1146/annurev-nutr-071714-034250 [Review, mostly animal data]

Mercury

  1. Clarkson TW, Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol. 2006;36(8):609-662. PMID: 16973445 · DOI: 10.1080/10408440600845619 [Review]
  2. Simmons-Willis TA, Koh AS, Clarkson TW, Ballatori N. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem J. 2002;367(Pt 1):239-246. PMID: 12117417 · DOI: 10.1042/BJ20020841 [In vitro, oocyte expression system]
  3. Franco JL, Posser T, Dunkley PR, Dickson PW, Mattos JJ, Martins R, Bainy AC, Marques MR, Dafre AL, Farina M. Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radic Biol Med. 2009;47(4):449-457. PMID: 19450679 · DOI: 10.1016/j.freeradbiomed.2009.05.013 [In vivo, mouse, and In vitro]
  4. Zemolin AP, Meinerz DF, de Paula MT, Mariano DO, Rocha JB, Pereira AB, Posser T, Franco JL. Evidences for a role of glutathione peroxidase 4 (GPx4) in methylmercury induced neurotoxicity in vivo. Toxicology. 2012;302(1):60-67. PMID: 22885222 · DOI: 10.1016/j.tox.2012.07.013 [In vivo, mouse]
  5. Farina M, Aschner M. Glutathione antioxidant system and methylmercury-induced neurotoxicity: An intriguing interplay. Biochim Biophys Acta Gen Subj. 2019;1863(12):129285. PMID: 30659883 · DOI: 10.1016/j.bbagen.2019.01.007 [Mechanism Review]
  6. Ralston NVC, Raymond LJ. Mercury's neurotoxicity is characterized by its disruption of selenium biochemistry. Biochim Biophys Acta Gen Subj. 2018;1862(11):2405-2416. PMID: 29753115 · DOI: 10.1016/j.bbagen.2018.05.009 [Mechanism Review]
  7. Ralston NV, Raymond LJ. Dietary selenium's protective effects against methylmercury toxicity. Toxicology. 2010;278(1):112-123. PMID: 20561558 · DOI: 10.1016/j.tox.2010.06.004 [Review, mostly animal data]
  8. Björkman L, Lundekvam BF, Laegreid T, Bertelsen BI, Morild I, Lilleng P, Lind B, Palm B, Vahter M. Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health. 2007;6:30. PMID: 17931423 · DOI: 10.1186/1476-069X-6-30 [Autopsy study, n=30]
  9. Rohling ML, Demakis GJ. A meta-analysis of the neuropsychological effects of occupational exposure to mercury. Clin Neuropsychol. 2006;20(1):108-132. PMID: 16393923 · DOI: 10.1080/13854040500203324 [Meta-analysis, k=36]
  10. Yokoo EM, Valente JG, Grattan L, Schmidt SL, Platt I, Silbergeld EK. Low level methylmercury exposure affects neuropsychological function in adults. Environ Health. 2003;2(1):8. PMID: 12844364 · DOI: 10.1186/1476-069X-2-8 [Cross-sectional, n=129]
  11. Weil M, Bressler J, Parsons P, Bolla K, Glass T, Schwartz B. Blood mercury levels and neurobehavioral function. JAMA. 2005;293(15):1875-1882. PMID: 15840862 · DOI: 10.1001/jama.293.15.1875 [Cross-sectional, n=474]
  12. Takeuchi H, Shiota Y, Yaoi K, Taki Y, Nouchi R, Yokoyama R, Kotozaki Y, Nakagawa S, Sekiguchi A, Iizuka K, Hanawa S, Araki T, Miyauchi CM, Sakaki K, Nozawa T, Ikeda S, Yokota S, Magistro D, Sassa Y, Kawashima R. Mercury levels in hair are associated with reduced neurobehavioral performance and altered brain structures in young adults. Commun Biol. 2022;5(1):529. PMID: 35655003 · DOI: 10.1038/s42003-022-03464-z [Cross-sectional with MRI, n=920]

Lead

  1. Neal AP, Guilarte TR. Molecular neurobiology of lead (Pb(2+)): effects on synaptic function. Mol Neurobiol. 2010;42(3):151-160. PMID: 21042954 · DOI: 10.1007/s12035-010-8146-0 [Mechanism Review]
  2. Meyer-Baron M, Seeber A. A meta-analysis for neurobehavioural results due to occupational lead exposure with blood lead concentrations <70 microg/100 ml. Arch Toxicol. 2000;73(10-11):510-518. PMID: 10663381 · DOI: 10.1007/s002040050002 [Meta-analysis]
  3. Seeber A, Meyer-Baron M, Schäper M. A summary of two meta-analyses on neurobehavioural effects due to occupational lead exposure. Arch Toxicol. 2002;76(3):137-145. PMID: 11967618 · DOI: 10.1007/s00204-001-0315-5 [Meta-analysis, summary of two meta-analyses]
  4. Shih RA, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect. 2007;115(3):483-492. PMID: 17431502 · DOI: 10.1289/ehp.9786 [Systematic Review, k=21]
  5. Weisskopf MG, Wright RO, Schwartz J, Spiro A, Sparrow D, Aro A, Hu H. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol. 2004;160(12):1184-1193. PMID: 15583371 · DOI: 10.1093/aje/kwh333 [Cohort, prospective, n=466]
  6. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, Todd AC, Shi W, Bassett S, Youssem D. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology. 2006;66(10):1476-1484. PMID: 16717205 · DOI: 10.1212/01.wnl.0000216138.69777.15 [Cross-sectional with MRI, n=532]
  7. Power MC, Korrick S, Tchetgen Tchetgen EJ, Nie LH, Grodstein F, Hu H, Weuve J, Schwartz J, Weisskopf MG. Lead exposure and rate of change in cognitive function in older women. Environ Res. 2014;129:69-75. PMID: 24529005 · DOI: 10.1016/j.envres.2013.12.010 [Cohort, prospective, n=584]
  8. Krieg EF Jr, Chrislip DW, Crespo CJ, Brightwell WS, Ehrenberg RL, Otto DA. The relationship between blood lead levels and neurobehavioral test performance in NHANES III and related occupational studies. Public Health Rep. 2005;120(3):240-251. PMID: 16134563 · DOI: 10.1177/003335490512000305 [Cross-sectional, NHANES III, plus occupational studies]
  9. Pawlas N, Dobrakowski M, Kasperczyk A, Kozłowska A, Mikołajczyk A, Kasperczyk S. The Level of Selenium and Oxidative Stress in Workers Chronically Exposed to Lead. Biol Trace Elem Res. 2016;170(1):1-8. PMID: 26179085 · DOI: 10.1007/s12011-015-0435-z [Cross-sectional, n=324]

Cadmium, arsenic, manganese, aluminum and overall view

  1. Wang B, Du Y. Cadmium and its neurotoxic effects. Oxid Med Cell Longev. 2013;2013:898034. PMID: 23997854 · DOI: 10.1155/2013/898034 [Review, cell and animal data]
  2. Li H, Wang Z, Fu Z, Yan M, Wu N, Wu H, Yin P. Associations between blood cadmium levels and cognitive function in a cross-sectional study of US adults aged 60 years or older. BMJ Open. 2018;8(4):e020533. PMID: 29654035 · DOI: 10.1136/bmjopen-2017-020533 [Cross-sectional, NHANES, n=2,068]
  3. Tyler CR, Allan AM. The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review. Curr Environ Health Rep. 2014;1(2):132-147. PMID: 24860722 · DOI: 10.1007/s40572-014-0012-1 [Review, human and rodent data]
  4. O'Bryant SE, Edwards M, Menon CV, Gong G, Barber R. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. Int J Environ Res Public Health. 2011;8(3):861-874. PMID: 21556183 · DOI: 10.3390/ijerph8030861 [Cross-sectional, n=434]
  5. O'Neal SL, Zheng W. Manganese Toxicity Upon Overexposure: a Decade in Review. Curr Environ Health Rep. 2015;2(3):315-328. PMID: 26231508 · DOI: 10.1007/s40572-015-0056-x [Review]
  6. Meyer-Baron M, Knapp G, Schäper M, van Thriel C. Performance alterations associated with occupational exposure to manganese: a meta-analysis. Neurotoxicology. 2009;30(4):487-496. PMID: 19465050 · DOI: 10.1016/j.neuro.2009.05.001 [Meta-analysis, k=13]
  7. Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976;294(4):184-188. PMID: 1244532 · DOI: 10.1056/NEJM197601222940402 [Autopsy study, case comparison]
  8. Soleimani H, Dehghani S, Abolli S, Alamdari HA, Gheisvandi O, Atlasi R, Yazdi NB, Tabatabaei-Malazy O, Soleimani Z, Handy RD. Environmental aluminum exposure and Alzheimer's disease risk: Evidence from a systematic review and meta-analysis. Ecotoxicol Environ Saf. 2025;302:118759. PMID: 40749395 · DOI: 10.1016/j.ecoenv.2025.118759 [Systematic Review and meta-analysis]
  9. Song Y, Chen Y, Fu Z, Wen Y, Zhao W, Li J, Wang H, Du Y, Deng Y. Heavy metal exposure and cognitive impairment: An umbrella review of meta-analyses. J Hazard Mater. 2025;498:139881. PMID: 40966995 · DOI: 10.1016/j.jhazmat.2025.139881 [Review, umbrella review of 83 meta-analyses]
  10. Sasaki N, Carpenter DO. Associations between Metal Exposures and Cognitive Function in American Older Adults. Int J Environ Res Public Health. 2022;19(4):2327. PMID: 35206515 · DOI: 10.3390/ijerph19042327 [Cross-sectional, NHANES, n=3,042]

Measuring and detox

  1. Ruha AM. Recommendations for provoked challenge urine testing. J Med Toxicol. 2013;9(4):318-325. PMID: 24113861 · DOI: 10.1007/s13181-013-0350-7 [Review]
  2. Frumkin H, Manning CC, Williams PL, Sanders A, Taylor BB, Pierce M, Elon L, Hertzberg VS. Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure? Environ Health Perspect. 2001;109(2):167-171. PMID: 11266328 · DOI: 10.1289/ehp.01109167 [Cross-sectional with control group, n=220]
  3. Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ, Rhoads GG; Treatment of Lead-Exposed Children Trial Group. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med. 2001;344(19):1421-1426. PMID: 11346806 · DOI: 10.1056/NEJM200105103441902 [RCT, n=780]
  4. Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, Fay ME, Davoli CT, Denckla MB, Bornschein RL, Schwarz D, Dockery DW, Adubato S, Jones RL; Treatment of Lead-Exposed Children Clinical Trial Group. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics. 2004;114(1):19-26. PMID: 15231903 · DOI: 10.1542/peds.114.1.19 [RCT, follow-up, n=647]
  5. Brown MJ, Willis T, Omalu B, Leiker R. Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005. Pediatrics. 2006;118(2):e534-e536. PMID: 16882789 · DOI: 10.1542/peds.2006-0858 [Case Reports, case series]

Selenium

  1. MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C, Burk RF, Dunn JR, Green AL, Hammond R, Schaffner W, Jones TF. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010;170(3):256-261. PMID: 20142570 · DOI: 10.1001/archinternmed.2009.495 [Outbreak investigation, 201 cases]
  2. Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA. Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE). JAMA Neurol. 2017;74(5):567-573. PMID: 28319243 · DOI: 10.1001/jamaneurol.2016.5778 [RCT, later cohort, n=7,540]
  3. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147(4):217-223. PMID: 17620655 · DOI: 10.7326/0003-4819-147-4-200708210-00175 [RCT, secondary analysis, n=1,202]

Brain fog and differential diagnosis

  1. McWhirter L, Smyth H, Hoeritzauer I, Couturier A, Stone J, Carson AJ. What is brain fog? J Neurol Neurosurg Psychiatry. 2023;94(4):321-325. PMID: 36600580 · DOI: 10.1136/jnnp-2022-329683 [Qualitative content analysis, 141 descriptions]
  2. McWhirter L, Ritchie C, Stone J, Carson A. Functional cognitive disorders: a systematic review. Lancet Psychiatry. 2020;7(2):191-207. PMID: 31732482 · DOI: 10.1016/S2215-0366(19)30405-5 [Systematic Review]
  3. Olaithe M, Bucks RS, Hillman DR, Eastwood PR. Cognitive deficits in obstructive sleep apnea: Insights from a meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation. Sleep Med Rev. 2018;38:39-49. PMID: 28760549 · DOI: 10.1016/j.smrv.2017.03.005 [Systematic Review, meta-review of 18 papers]
  4. Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029-2040. PMID: 24168753 · DOI: 10.1017/S0033291713002535 [Meta-analysis]
  5. Hampshire A, Azor A, Atchison C, Trender W, Hellyer PJ, Giunchiglia V, Husain M, Cooke GS, Cooper E, Lound A, Donnelly CA, Chadeau-Hyam M, Ward H, Elliott P. Cognition and Memory after Covid-19 in a Large Community Sample. N Engl J Med. 2024;390(9):806-818. PMID: 38416429 · DOI: 10.1056/NEJMoa2311330 [Cross-sectional, population-based, n=112,964]
  6. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135. PMID: 34973396 · DOI: 10.1016/j.bbi.2021.12.020 [Meta-analysis, k=81]
  7. Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):377-383. PMID: 25122491 · DOI: 10.1097/MED.0000000000000089 [Review]
  8. Maki PM, Jaff NG. Brain fog in menopause: a health-care professional's guide for decision-making and counseling on cognition. Climacteric. 2022;25(6):570-578. PMID: 36178170 · DOI: 10.1080/13697137.2022.2122792 [Review, White Paper of the International Menopause Society]
  9. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr. 2007;85(3):778-787. PMID: 17344500 · DOI: 10.1093/ajcn/85.3.778 [RCT, n=149 at baseline]
  10. Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019;179(8):1084-1093. PMID: 31233095 · DOI: 10.1001/jamainternmed.2019.0677 [Case-control, nested case-control study]
Transparency on the evidence: where the data are thin
  1. No study has brain fog as an endpoint. The human studies measure test performance or cognitive impairment, which only partly overlaps with brain fog.
  2. GPX4, ferroptosis and the selenium hierarchy come from cell and mouse models, often with a complete genetic knockout of an enzyme. Transferring this to slightly reduced activity in humans is mechanistically plausible, but not established.
  3. The mercury animal models by Franco and Zemolin used 40 mg methylmercury per liter of drinking water, far above any everyday exposure.
  4. The conditioned selenium deficiency caused by mercury is a well-founded hypothesis from one research group and has not been conclusively proven in humans. Elsewhere, the papers by Ralston and Raymond contain statements about fish consumption that were deliberately not adopted here.
  5. The human findings at everyday exposure are cross-sectional studies, partly pointing in contradictory directions. Krieg and Weil found no clear association; Li, Sasaki, Takeuchi and O'Bryant found weak associations. Cross-sectional studies do not establish cause.
  6. The TLC trial studied young children with lead, not adults with brain fog and not mercury. It is the key randomized trial available on reversibility, but not a direct answer to your situation.
  7. The RKI commission statement dates from 2007 and refers explicitly to mercury from amalgam. It is not an AWMF guideline. The ACMT paper is the position of a US professional society.
  8. The DEGAM guideline covers fatigue, not brain fog as a condition in its own right. It does, however, explicitly name cognitive complaints. The cited version dates from 11/2022, and a revision has been announced. A newer version could not be found at the time of research on 16 September 2026.
  9. The selenium studies have their own limitations. The poisoning outbreak was due to a manufacturing error, in Stranges diabetes was a secondary endpoint, and PREADViSE studied dementia in men without complaints. All dose figures are study figures and not a recommendation.
  10. Some pointers in the practical section are phrased in general terms, for example on hobbies, water pipes in old buildings or tobacco smoke as a source of cadmium. They do not come from the studies cited here and are meant as prompts for the conversation with your doctor.
  11. What is deliberately not included here. No detox protocol, no dose for chelating agents, selenium or other supplements, no product names, no table of reference values and no advice to stop, reduce or replace a prescribed medication. No paragraph implies that a psychiatric, psychotherapeutic, neurological or general practice workup should be postponed. What I describe from my consulting room is labeled as observation and is not a study result.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment